Dr. Loh Wann Jia is a senior consultant endocrinologist and Head of Lipid Unit in Changi General Hospital Singapore. Her subspecialty interest in metabolic conditions including dyslipidaemia, obesity, atypical diabetes, and insulin resistant states. She graduated from Imperial College London (U.K.) with Distinction and an intercalated degree of Bachelor of Science (BSc) in Endocrinology with 1st class honours. She has undertaken clinical and research fellowships in London (2017) and in Australia (2022).

Professor Chih-Yuan Wang currently serves as Chief of the Division of Endocrinology and Metabolism and Deputy Director of the Department of Internal Medicine at National Taiwan University Hospital (NTUH). He is also a Professor of Medicine at the College of Medicine, National Taiwan University, where he plays a key role in advancing endocrine and metabolic research, education, and clinical innovation in Taiwan. Professor Wang received his M.D. from Chung-Shan Medical University, followed by a Ph.D. in Physiology and an EMBA from National Taiwan University. He is a board-certified endocrinologist and certified diabetes educator, with more than three decades of clinical and academic experience. His primary research interests include diabetes therapeutics, cardio-renal-metabolic (CKM) syndrome, thyroid disorders, and biomarker discovery through urinary exosomal peptides. Professor Wang has made significant contributions to understanding the real-world effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists, as well as to developing novel urinary biomarkers for thyroid cancer diagnosis and postoperative surveillance. He has published extensively in leading international journals such as The Lancet Healthy Longevity, Journal of Clinical Endocrinology & Metabolism, and Diabetes Research and Clinical Practice. His academic leadership has been recognized through numerous prestigious honors, including the Professor Xiao-Ren Pan Distinguished Research Award of the Asian Association for the Study of Diabetes (AASD, 2025), the Dr. Liao Xuezhi Endocrine Award (2025), and the 21st Taiwan National Innovation Award for Academic Research (2024). Dedicated to bridging clinical excellence with translational science, Professor Wang continues to lead multi-center collaborations across Asia, integrating big-data analytics, AI-driven risk modeling, and precision endocrinology to improve patient care and reshape the future of metabolic medicine.

Associate Professor Andrew Lin is a consultant cardiologist and Academic Lead of Non-Invasive Imaging at the Victorian Heart Hospital. He has completed three years of fellowship training in advanced cardiac imaging, including echocardiography at MonashHeart and cardiac CT and cardiac MRI at the world-leading Cedars-Sinai Medical Center, Los Angeles, USA, and Barts Heart Centre, London, UK. He runs a research program focused on the discovery and application of novel imaging biomarkers to improve diagnostic and prognostic precision. He has received multiple international young investigator awards for his cardiac CT research, including from the American College of Cardiology and Society of Cardiovascular Computed Tomography. He is a NHMRC Emerging Leadership Fellow and prior Heart Foundation Postdoctoral Fellow.

Associate Professor Sandra Neoh is an endocrinologist at Northern Health and Austin Health in Melbourne, and a former Gates Cambridge scholar. Her clinical interests include diabetes, lipidology, obesity and Aboriginal Health. She holds a number of clinical leadership positions and is the current co-chair of the Australian Atherosclerosis Society's Cardiometabolic and Vascular Medicine Council.

Associate Professor Andrew Lin is a consultant cardiologist and Academic Lead of Non-Invasive Imaging at the Victorian Heart Hospital. He has completed three years of fellowship training in advanced cardiac imaging, including echocardiography at MonashHeart and cardiac CT and cardiac MRI at the world-leading Cedars-Sinai Medical Center, Los Angeles, USA, and Barts Heart Centre, London, UK. He runs a research program focused on the discovery and application of novel imaging biomarkers to improve diagnostic and prognostic precision. He has received multiple international young investigator awards for his cardiac CT research, including from the American College of Cardiology and Society of Cardiovascular Computed Tomography. He is a NHMRC Emerging Leadership Fellow and prior Heart Foundation Postdoctoral Fellow.

Associate Professor Sandra Neoh is an endocrinologist at Northern Health and Austin Health in Melbourne, and a former Gates Cambridge scholar. Her clinical interests include diabetes, lipidology, obesity and Aboriginal Health. She holds a number of clinical leadership positions and is the current co-chair of the Australian Atherosclerosis Society's Cardiometabolic and Vascular Medicine Council.

Anita is a patient advocate with over 10 years of experience, driven by 28 years of living with Type 1 Diabetes, later diagnosed with cardiomyopathy and chronic kidney disease. She works to improve access to care, reduce stigma, and amplify patient voices. Through collaboration with advocacy groups, health professionals, and policymakers, she pushes for systemic change and support inclusive diabetes care, especially for women and young adults.